Project title:
Studies on the stability, specificity, and molecular composition of the innovative CardioBind test assessing the binding capacity of stem cells to cardiac tissue under in vitro conditions for applications in personalized medicine
Project description and tasks:
The project, implemented by Target Cells Sp. z o.o. in cooperation with the Jagiellonian University acting as a subcontractor, involves the execution of research and development activities aimed at the validation of the CardioBind diagnostic tool.
The project is co-financed by the European Union.
The following tasks are carried out within the project:
- conducting physicochemical and microbiological stability studies of the test,
- performing proteomic analyses to identify protein isoforms,
- verification of the specificity of stem cell binding to cardiac tissue under in vitro conditions.
Target groups:
The project is addressed to entities operating in the field of regenerative medicine and cardiology, in particular research centres, scientific institutions, and healthcare entities conducting research on cell-based therapies.
Project objectives and results:
The objective of the project is to confirm the effectiveness, durability, and specificity of the CardioBind test as a tool supporting the development of personalized medicine.
The result of the project will be a laboratory-validated diagnostic test intended for research applications in the field of regenerative medicine, enabling the assessment of the interaction potential between stem cells and cardiac tissue.
Project value: 368 926,20 PLN
European Union contribution: 254 949,00 PLN